Clinical Trial Update: Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy [Phase 2]

View source ↗

Summary

A Phase 2 feasibility trial is evaluating fluorescence imaging with Bevacizumab-800CW during bronchoscopy to help visualize lung tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lymph Node Metastasis
• Pulmonary Nodules

Drugs mentioned

• Bevacizumab-800CW (bevacizumab-800CW)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Lung Neoplasms, Pulmonary Neoplasms | Phase 2 | Status: NOT_YET_RECRUITING